跳至主要内容
临床试验/JPRN-UMIN000010672
JPRN-UMIN000010672已完成未知

Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan - Immunogenicity and safety after booster vaccination of DTP in young adults

Saga University0 个研究点目标入组 100 人开始时间: 2013年5月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

Significant increases were found in the antibodies against pertussis toxin, filamentous hemagglutinin, diphtheria toxoid, and tetanus toxoid after booster vaccination in both groups, and the booster response rates for all reached 100%.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 20years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • if their antibody level against PT was equal to or higher than 100 EU/mL in 2010; if they had any history of diphtheria, tetanus, and pertussis; if they had received any other drug or vaccine within 30 days of entry; if they had a history of allergic reactions to any vaccine component; if they had received immunoglobulins or any blood products; if they had an acute disease or a febrile illness at the time of vaccination.

研究者

相似试验